Armas Pharmaceuticals Inc.

Mar 16, 2020

Armas Pharmaceuticals COVID-19 Statement

Jan 20, 2020

Armas Pharmaceuticals Adds Four Generic Injectables As First Launches of 2020

Nov 13, 2019

Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib

May 28, 2019

Armas and Micro Labs Announce Collaboration To Launch Generic Injectables to U.S. Market

May 07, 2019

Armas Pharmaceuticals Continues to Add to Portfolio With Launch of Second Oncology Injectable

Apr 08, 2019

Armas Pharmaceuticals Expands Generic Portfolio with Launches of Capecitabine and Imatinib

Nov 19, 2018

Armas Pharmaceuticals Announces the Launch of Their First Injectable Product to U.S. Market

Oct 08, 2018

Armas and Shilpa Enter into a Sales and Distribution Agreement to Bring High quality oncology products to U.S. Market